Related Experiment Video
Updated: Jul 4, 2026

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
Management of facial blushing
Peter B Licht1, Hans K Pilegaard
1Department of Cardiothoracic Surgery, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark. peter.licht@ouh.regionsyddanmark.dk
Facial blushing can be treated with thoracoscopic sympathectomy, especially when emotionally triggered. Careful patient selection and managing side effects are crucial for successful surgical outcomes in treating facial blushing.
Area of Science:
- Dermatology
- Surgical Procedures
- Psychosomatic Medicine
Background:
- Facial blushing is a common concern that can significantly impact quality of life.
- It can be triggered by emotions and may indicate underlying medical conditions.
Purpose of the Study:
- To investigate the diagnostic and treatment approaches for facial blushing.
- To evaluate the efficacy and patient satisfaction with thoracoscopic sympathectomy for facial blushing.
Main Methods:
- Initial medical evaluation by dermatologists or internists to exclude serious disorders.
- Consideration of nonsurgical options for emotionally triggered blushing.
- Thoracoscopic sympathectomy as a treatment for specific types of facial blushing.
Main Results:
- Thoracoscopic sympathectomy is effective for sympathetically mediated, uncontrollable facial blushing.
- While side effects are frequent, most patients report satisfaction with the surgery.
- Meticulous patient selection and informed consent are vital for short-term success.
Conclusions:
- Facial blushing warrants medical investigation to rule out underlying conditions.
- Nonsurgical treatments should be considered first for emotionally triggered blushing.
- Further research comparing surgical, pharmacologic, and psychotherapeutic treatments is needed for long-term success.
Related Concept Videos
Managing Impressions
Angina IV: Management
Facial Feedback Hypothesis
Blinding
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
